Strategic Alliances and Collaborations (Tables)

12 Months Ended

Dec. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Revenue from Strategic Alliances

The following table summarizes our total revenues from our strategic alliances and collaborations during the periods presented (in thousands):

	Year ended December 31,
	2016		2015		2014
AstraZeneca	$	1,122	$	18,871	$	1,859
Sanofi	72		71		979
GSK	—		—		3,509
Biogen	—		1,817		1,122
Other	—		—		200
Total	$	1,194	$	20,759	$	7,669